
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 99.400 | 99.400 | 0.000 |
Other | 0.800 | 0.800 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.438 | 19.703 |
Price to Book | 3.228 | 3.888 |
Price to Sales | 1.620 | 2.230 |
Price to Cash Flow | 13.010 | 14.907 |
Dividend Yield | 2.789 | 1.492 |
5 Years Earnings Growth | 9.398 | 10.158 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 48.780 | 94.291 |
Financial Services | 24.440 | 7.593 |
Consumer Cyclical | 15.210 | 6.735 |
Consumer Defensive | 4.570 | 3.276 |
Real Estate | 2.780 | 1.225 |
Technology | 2.430 | 5.062 |
Industrials | 1.790 | 3.295 |
Number of long holdings: 152
Number of short holdings: 98
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Life Financial | CA8667961053 | 3.32 | 85.60 | +0.71% | |
Allianz | DE0008404005 | 3.04 | 341.50 | -0.87% | |
MetLife | US59156R1086 | 2.98 | 78.56 | +0.99% | |
BlackRock | US09290D1019 | 2.93 | 1,123.28 | +0.44% | |
Novo Nordisk B | DK0062498333 | 2.88 | 452.1 | +1.14% | |
Legal & General | GB0005603997 | 2.86 | 256.30 | -0.54% | |
SCI | US8175651046 | 2.68 | 76.02 | -0.26% | |
Manulife Financial | CA56501R1064 | 2.58 | 31.32 | +0.58% | |
Eli Lilly | US5324571083 | 2.53 | 812.69 | +0.90% | |
Boston Scientific | US1011371077 | 2.42 | 106.14 | -0.07% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1530900684 | 3.25B | -8.52 | 10.92 | - | ||
LU1530899142 | 3.25B | -8.93 | 9.84 | - | ||
LU2035461495 | 3.25B | -8.70 | 10.18 | - | ||
LU1903290036 | 3.25B | -1.97 | 12.51 | - | ||
LU1902444402 | 1.83B | -3.39 | 9.34 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review